Latest News and Press Releases

New York, United States, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Somatotropin, or human growth hormone, is a peptide hormone made by the pituitary gland that controls cell growth, reproduction,...

Er-Kim broadens drug distribution for novel rare endocrinology disease therapies in CEE and Eurasian markets

Wilmington, Delaware, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Automatic Immunoassay Analyzer Market by Product (Immunofluorescence, Chemiluminescence,...

New YPrime research report sheds light on how technology can help solve challenges in endocrinology clinical trials.

Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.

Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey

Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The immunoassay market was valued at US$ 31.5 billion in 2022. A CAGR of 5.0% is expected...

LOUISVILLE, Ky., Dec. 05, 2023 (GLOBE NEWSWIRE) -- In her new book, “Diabetes and Me: Living a Healthy and Empowered Life in the Face of Diabetes” (ISBN-13 9781633310803, Nov. 14, 2023),...

Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed...

Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Program